Metaxalone
NDC Package 64720-321-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Metaxalone is used to treat muscle spasms/pain. Marketed by Corepharma, Llc, this product is identified by NDC 64720-321 and is authorized under FDA application NDA013217.

Identification & Billing

NDC Package Code
64720-321-50
Package Description
500 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
64720032150

Clinical Specifications

Proprietary Name
Metaxalone
Dosage Form
-
Usage Information
Metaxalone is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment.

Regulatory & Marketing

Labeler Name
Corepharma, Llc
FDA Application #
NDA013217
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-01-2007
End Marketing Date
04-01-2020
Listing Expiration
04-01-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64720-321). Click a package code to view its specific billing and regulatory data.

100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64720-321-50 identifies a specific commercial package of 500 tablet in 1 bottle of Metaxalone, labeled by Corepharma, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Corepharma, Llc on November 01, 2007. The current certification is valid through April 01, 2020.

What are the primary indications for this medication?

Metaxalone is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment.

How is this Corepharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64720032150. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64720-321-50
11-Digit CMS (5-4-2)
64720-0321-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.